A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO (PREVENT Study)

Name: A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO (PREVENT Study)
License: Public Domain

Alexion Pharmaceuticals, Inc.

ClinicalTrials.gov · Datasets · License: Public Domain

neuromyelitis optica, neuromyelitis optica spectrum disorder

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 405219
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.